ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 76 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,800 | -13.0% | 6,000 | 0.0% | 0.00% | – |
Q2 2023 | $2,070 | -67.2% | 6,000 | -25.3% | 0.00% | – |
Q1 2023 | $6,305 | -10.7% | 8,032 | +13.8% | 0.00% | – |
Q4 2022 | $7,060 | +17.7% | 7,060 | +0.9% | 0.00% | – |
Q3 2022 | $6,000 | -57.1% | 7,000 | -45.5% | 0.00% | – |
Q2 2022 | $14,000 | -69.6% | 12,848 | -61.3% | 0.00% | – |
Q1 2022 | $46,000 | -69.1% | 33,217 | -49.4% | 0.00% | – |
Q4 2021 | $149,000 | -38.2% | 65,608 | +13.5% | 0.00% | – |
Q3 2021 | $241,000 | -8.4% | 57,829 | +4.6% | 0.00% | – |
Q2 2021 | $263,000 | +57.5% | 55,306 | +175.2% | 0.00% | – |
Q1 2021 | $167,000 | +475.9% | 20,100 | +235.0% | 0.00% | – |
Q4 2020 | $29,000 | +190.0% | 6,000 | -0.4% | 0.00% | – |
Q3 2020 | $10,000 | -41.2% | 6,024 | +0.4% | 0.00% | – |
Q2 2020 | $17,000 | +13.3% | 6,000 | +20.0% | 0.00% | – |
Q1 2020 | $15,000 | -62.5% | 5,000 | -50.1% | 0.00% | – |
Q4 2019 | $40,000 | -64.3% | 10,015 | -55.4% | 0.00% | – |
Q3 2019 | $112,000 | -41.7% | 22,443 | -22.1% | 0.00% | – |
Q2 2019 | $192,000 | – | 28,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
Jump Financial, LLC | 58,225 | $276,000 | 0.03% |